NCT01415882 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 35
- group Id
- BG003
- value
- 37
- group Id
- BG004
- value
- 24
- group Id
- BG005
- value
- 165
- units
- Participants
- groups
- description
- Patients receive ixazomib citrate PO on days 1, 8, and 15. Patients with lack of minor response by the end of the second cycle or lack of partial response by the end of the fourth cycle also receive dexamethasone PO on days 1, 2, 8, 9, 15, and 16. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG000
- title
- Arm A (Ixazomib Citrate and Dexamethasone, Closed to Accrual)
- description
- Patients receive ixazomib citrate PO on days 1, 8, and 15 and dexamethasone PO on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG001
- title
- Arm B (Ixazomib Citrate and Dexamethasone)
- description
- Patients receive higher doses of ixazomib citrate PO on days 1, 8, and 15 and dexamethasone PO on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG002
- title
- Arm C (Higher-dose Ixazomib Citrate and Dexamethasone)
- description
- Patients receive ixazomib citrate PO on days 1, 8, and 15 and cyclophosphamide PO (cycles 1-18 only) and dexamethasone PO on days 1, 8, 15, and 22. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG003
- title
- Arm D (Ixazomib Citrate, Dexamethasone, and Cyclophosphamide)
- description
- Patients receive ixazomib citrate PO on days 1, 8, and 15, cyclophosphamide PO (cycles 1-12 only) on days 1, 8, 15, 22, and daratumumab IV on days 1, 8, 15, 22 (cycles 1-2), days 1 and 15 (cycles 3-6), and day 1 in all subsequent cycles. Patients also receive dexamethasone IV or PO on days 1, 8, 15, and 22. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG004
- title
- Arm E (Ixazomib Citrate, Cyclophosphamide, Daratumumab)
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.4
- value
- 66.3
- group Id
- BG001
- spread
- 8.4
- value
- 70.0
- group Id
- BG002
- spread
- 7.9
- value
- 67.8
- group Id
- BG003
- spread
- 10.6
- value
- 69.1
- group Id
- BG004
- spread
- 8.7
- value
- 68.1
- group Id
- BG005
- spread
- 9.1
- value
- 68.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 15
- group Id
- BG004
- value
- 6
- group Id
- BG005
- value
- 68
- title
- Female
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 22
- group Id
- BG004
- value
- 18
- group Id
- BG005
- value
- 97
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 6
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 32
- group Id
- BG003
- value
- 36
- group Id
- BG004
- value
- 24
- group Id
- BG005
- value
- 156
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 35
- group Id
- BG003
- value
- 36
- group Id
- BG004
- value
- 24
- group Id
- BG005
- value
- 164
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 35
- group Id
- BG003
- value
- 37
- group Id
- BG004
- value
- 24
- group Id
- BG005
- value
- 165
- units
- Participants
- groups
- description
- Patients receive ixazomib citrate PO on days 1, 8, and 15. Patients with lack of minor response by the end of the second cycle or lack of partial response by the end of the fourth cycle also receive dexamethasone PO on days 1, 2, 8, 9, 15, and 16. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG000
- title
- Arm A (Ixazomib Citrate and Dexamethasone, Closed to Accrual)
- description
- Patients receive ixazomib citrate PO on days 1, 8, and 15 and dexamethasone PO on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG001
- title
- Arm B (Ixazomib Citrate and Dexamethasone)
- description
- Patients receive higher doses of ixazomib citrate PO on days 1, 8, and 15 and dexamethasone PO on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG002
- title
- Arm C (Higher-dose Ixazomib Citrate and Dexamethasone)
- description
- Patients receive ixazomib citrate PO on days 1, 8, and 15 and cyclophosphamide PO (cycles 1-18 only) and dexamethasone PO on days 1, 8, 15, and 22. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG003
- title
- Arm D (Ixazomib Citrate, Dexamethasone, and Cyclophosphamide)
- description
- Patients receive ixazomib citrate PO on days 1, 8, and 15, cyclophosphamide PO (cycles 1-12 only) on days 1, 8, 15, 22, and daratumumab IV on days 1, 8, 15, 22 (cycles 1-2), days 1 and 15 (cycles 3-6), and day 1 in all subsequent cycles. Patients also receive dexamethasone IV or PO on days 1, 8, 15, and 22. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG004
- title
- Arm E (Ixazomib Citrate, Cyclophosphamide, Daratumumab)
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.4
- value
- 66.3
- group Id
- BG001
- spread
- 8.4
- value
- 70.0
- group Id
- BG002
- spread
- 7.9
- value
- 67.8
- group Id
- BG003
- spread
- 10.6
- value
- 69.1
- group Id
- BG004
- spread
- 8.7
- value
- 68.1
- group Id
- BG005
- spread
- 9.1
- value
- 68.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 15
- group Id
- BG004
- value
- 6
- group Id
- BG005
- value
- 68
- title
- Female
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 22
- group Id
- BG004
- value
- 18
- group Id
- BG005
- value
- 97
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 6
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 32
- group Id
- BG003
- value
- 36
- group Id
- BG004
- value
- 24
- group Id
- BG005
- value
- 156
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 35
- group Id
- BG003
- value
- 36
- group Id
- BG004
- value
- 24
- group Id
- BG005
- value
- 164
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle